Foresite Capital Management IV, LLC (CIK 1704132) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-06). Recent activity: Buy EIKN (1.3M shares), Buy EIKN (335,521 shares), Buy EIKN (37,855 shares), Buy EIKN (229,428 shares), Buy EIKN (697,885 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1.3M | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 335,521 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 229,428 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 697,885 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 1,626 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 67,207 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 458,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 348,942 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 37,855 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 922 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 38,133 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 408,725 | $0 |
| 2026-02-06 | Eikon Therapeutics, Inc. (EIKN) | 10% Owner | Buy | 55,555 | $999,990 |
来源：SEC Form 4 申报文件 · 截至 2026-02-06